Found 167 matching trials
Effect of Chronic Incretin-based Therapy in Cystic Fibrosis NA In recent years, diabetes has emerged as one of the most significant co-dis...
Show More Location
Children's Hospital of Philadelphia and University of Pennsylvania
Learn More & Join Trial
Sitagliptin Mechanism of Action Study in Patients With Type 2 Diabetes Mellitus (0431-059) PHASE1 A clinical study to determine the safety, efficacy and the way sitagliptin ...
Show More Location
Multiple Locations
Learn More & Join Trial
Sitagliptin and Endothelial Dysfunction PHASE3 Over the years, numbers of cardioprotective drugs have been evaluated to at...
Show More Location
Kyung Hee University Hospital
Learn More & Join Trial
Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128) PHASE3 This study will examine the safety and efficacy of the addition of sitaglip...
Show More Location
Multiple Locations
Learn More & Join Trial
Emulation of the STEP-HFpEF DM Heart Failure Trial in Healthcare Claims Data N/A Investigators are building an empirical evidence base for real-world data t...
Show More Location
Brigham and Women's Hospital
Learn More & Join Trial
A Study to Test the Effectiveness and Safety of MK0893 in Combination With Other Drugs Used to Treat Type 2 Diabetes (0893-015) PHASE2 This study will test the effectiveness and safety of treatment with MK-0893...
Show More Location
Multiple Locations
Learn More & Join Trial
Effects of Sitagliptin on Gastric Emptying in Healthy Subjects PHASE1 The purpose of this study is to determine the effects of the drug, sitaglip...
Show More Location
Discipline of Medicine, Royal Adelaide Hospital
Learn More & Join Trial
IDG-16177 for the Evaluation of Its Safety and Pharmacokinetics PHASE1 This is a Phase I, first-in-human, randomised, double-blinded, placebo-and ...
Show More Location
Parexel International GmbH Early Phase Clinical Unit Klinikum Westend
Learn More & Join Trial
Feed-Back Suppression of Meal-Induced Glucagon-like Peptide 1 (GLP-1) Secretion PHASE1 The present study is a phase I, single-centre, double-blind, randomized, cr...
Show More Location
Diabeteszentrum Bad Lauterberg
Learn More & Join Trial
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin PHASE4 The purpose of this study is to assess the effect of canagliflozin (JNJ-284...
Show More Location
Multiple Locations
Learn More & Join Trial